| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
| 08/10/2004 | US6774112 Antidiabetic agents; cardiovascular disorders |
| 08/10/2004 | US6774111 Carbohydrate system and a method for providing nutrition to a diabetic |
| 08/10/2004 | US6774109 Inhibition of amylin release |
| 08/10/2004 | US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 08/10/2004 | US6773924 Such as iron hydroxide and sodium iron gluconate in glucose; blood disorders; storage stability |
| 08/10/2004 | US6773912 Lantibiotic |
| 08/10/2004 | US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in |
| 08/10/2004 | US6773881 By modulating vascular endothelial growth factor (vegf) |
| 08/10/2004 | US6773724 Improved solubility |
| 08/10/2004 | US6773723 Collagen/polysaccharide bilayer matrix |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773702 Treating immune suppression in a warm-blooded animal bearing a tumor; immunotherapy |
| 08/05/2004 | WO2004065932A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | WO2004064889A2 Intradermal cellular delivery using narrow gauge micro-cannula |
| 08/05/2004 | WO2004064867A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 08/05/2004 | WO2004064866A1 Combined use of carnosinase inhibitor with l-carnosines and composition |
| 08/05/2004 | WO2004064847A1 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers |
| 08/05/2004 | WO2004064846A1 Compositions and methods for combination antiviral therapy |
| 08/05/2004 | WO2004064845A1 Compositions and methods for combination antiviral therapy |
| 08/05/2004 | WO2004064844A1 Method for inhibition of necrosis induced by neurotrophin |
| 08/05/2004 | WO2004064838A1 Pharmaceutical compositions and methods for treating multidrug resistant cancer |
| 08/05/2004 | WO2004064833A1 Clindamycin phosphate foam |
| 08/05/2004 | WO2004064832A2 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | WO2004064820A2 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels |
| 08/05/2004 | WO2004064815A1 Oral dosage formulation |
| 08/05/2004 | WO2004064803A1 Topical pharmaceutical and/or cosmetic dispense systems |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064777A2 Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer |
| 08/05/2004 | WO2004064769A2 Methods for making and using topical delivery agents |
| 08/05/2004 | WO2004064738A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/05/2004 | WO2004064734A2 Combination therapies for the treatment of cancer |
| 08/05/2004 | WO2004064727A2 Method of cancer treatment using hdac inhibitors |
| 08/05/2004 | WO2004064725A2 Oral compositions and methods for treatment of adverse effects or radiation |
| 08/05/2004 | WO2004064719A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 08/05/2004 | WO2004064715A2 Polyhydroxylated pyrrolizidine |
| 08/05/2004 | WO2004050615A3 Method of increasing neutrophil production using 2,3-benzodiazepines |
| 08/05/2004 | WO2004050033A3 Method of treating cancers |
| 08/05/2004 | WO2004043377A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 08/05/2004 | WO2004041809A3 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 08/05/2004 | WO2004041257A3 Novel nutraceutical compositions comprising epigallocatechin gallate |
| 08/05/2004 | WO2004041159A3 Composition and method for enhancing immune response of swine |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004024070A3 Factors that bind intestinal toxins |
| 08/05/2004 | WO2004021969A3 Non-nucleoside reverse transcriptase inhibitors |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2004000226A3 Liposomes containing biologically active compounds |
| 08/05/2004 | WO2003070204A3 Lipase inhibiting composition |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152759 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152752 Administering cyclooxygenase inhibitor; topical administering |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152746 Treatment of scarring and related conditions using ppar-gamma activators |
| 08/05/2004 | US20040152713 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | US20040152710 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 08/05/2004 | US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism |
| 08/05/2004 | US20040152700 Novel use of 2-phenyl-substituted imidazotriazinones |
| 08/05/2004 | US20040152673 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152661 Methods and compositions for treating viral diseases |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152649 For prophylaxis and therapy of infectious disease, allergy, cancer |
| 08/05/2004 | US20040152644 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152643 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152642 For therapy of of neoplastic diseases |
| 08/05/2004 | US20040152637 To assess the risk of individuals to suffer from vascular contraction of coronary arteries in mammals; for therapy of vascular contraction of coronary arteries |
| 08/05/2004 | US20040152630 14-3-3 Binding molecules as sensitizers for anticancer therapies |
| 08/05/2004 | US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof |
| 08/05/2004 | US20040152623 Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152111 Compositions and methods for diagnosing and treating mood disorders |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152071 Complex of transferrins or transcobalamin with viricides; prevention reproduction of virus |
| 08/05/2004 | US20040152042 Dispensing apparatus and cartridge with deformable tip |
| 08/05/2004 | US20040151791 an analgesic selected from morphine, meperidine, fentanyl, hydromorphone, oxymorphone, oxycodone, hydrocodone, methadone, propoxyphene, pentazocine, levorphanol and combinations and a stool softener |
| 08/05/2004 | US20040151783 Therapeutic compositions |
| 08/05/2004 | US20040151774 Therapeutic compositions for drug delivery to and through covering epithelia |
| 08/05/2004 | US20040151770 e.g., tiotropium, oxitropium or ipratropium salt and (S)-N-[2-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-2-[4-(2-hydroxy-1-hydroxymethyl-ethylamino)-piperidin-1-yl]-N-methyl-2-phenylacetamide or salt; respiratory diseases |
| 08/05/2004 | US20040151759 Non-animal product containing veterinary formulations |
| 08/05/2004 | US20040151757 Use of medium-chain triglycerides (MCT) for optimisation as to nutrition physiology of the fatty acid spectrum in a dietary foodstuff for diabetics |